0591-2475 NDC - TETRACYCLINE HYDROCHLORIDE

Drug Information

  • Product NDC: 0591-2475
  • Proprietary Name:
  • Non Proprietary Name: Tetracycline Hydrochloride
  • Active Ingredient(s): 500 mg/1 TETRACYCLINE HYDROCHLORIDE 500 mg/1 TETRACYCLINE HYDROCHLORIDE
  • Administration Route(s):
  • Dosage Form(s): CAPSULE
  • Pharmacy Class(es): Tetracycline-class Antimicrobial [EPC]; Tetracyclines [CS]

Labeler Information

Field Name Field Value
Labeler Name: Actavis Pharma, Inc.
Product Type: DRUG FOR FURTHER PROCESSING
FDA Application Number:
Marketing Category: DRUG FOR FURTHER PROCESSING
Start Marketing Date:8/15/2011
End Marketing Date:6/10/2016

Package Information

No. Package Code Package Description Billing Unit
10591-2475-0015480 CAPSULE in 1 BOX (0591-2475-00)
20591-2475-01100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01)EA
30591-2475-01100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01)EA
40591-2475-101000 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-10)

NDC Record

Field Name Field Value Definition
PRODUCT NDC0591-2475The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE8/15/2011This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEActavis Pharma, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC0591-2475The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE8/15/2011This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEActavis Pharma, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC0591-2475The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE8/15/2011This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEDRUG FOR FURTHER PROCESSINGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEActavis Pharma, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025